Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Buildings (2016)

Lisata Therapeutics (LSTA) has disclosed Buildings for 4 consecutive years, with $13.0 million as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Buildings rose 12.98% year-over-year to $13.0 million, compared with a TTM value of $13.0 million through Dec 2016, up 12.98%, and an annual FY2016 reading of $13.0 million, up 12.98% over the prior year.
  • Buildings was $13.0 million for Q4 2016 at Lisata Therapeutics, up from $11.5 million in the prior quarter.
  • Across five years, Buildings topped out at $13.0 million in Q4 2016 and bottomed at $9.9 million in Q4 2012.
  • Average Buildings over 3 years is $11.4 million, with a median of $11.5 million recorded in 2015.
  • The sharpest move saw Buildings rose 0.24% in 2012, then rose 12.98% in 2016.
  • Year by year, Buildings stood at $9.9 million in 2012, then grew by 15.97% to $11.5 million in 2015, then grew by 12.98% to $13.0 million in 2016.
  • Business Quant data shows Buildings for LSTA at $13.0 million in Q4 2016, $11.5 million in Q4 2015, and $9.9 million in Q4 2012.